Mirnite Meltab 15 Tablet DT
Images are for reference. Actual packaging may vary.
Mirtazapine (15mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Mirtazapine antagonizes central alpha-2 adrenergic receptors, increasing norepinephrine and serotonin release.
Medical applications
Mirnite Meltab 15 Tablet DT is a delayed-release tablet containing 15mg of mirtazapine, an antidepressant agent used in the treatment of major depressive episodes and generalized anxiety disorder. It belongs to the piperazine group of compounds and works by selectively blocking the effects of certain neurotransmitters, such as serotonin and norepinephrine, in the brain. The delayed-release formulation is designed to release the active ingredient slowly over a period of time, allowing for consistent and sustained therapeutic effects.
Mirnite Meltab 15 Tablet DT is administered orally once daily, preferably in the evening, with or without food. The medication is available in a tablet form with a smooth, rounded surface and a distinctive minty flavor. Patients should be monitored closely for any signs of adverse reactions, which may include dizziness, drowsiness, dry mouth, and changes in appetite or sleep. Regular blood tests may also be necessary to monitor liver function and detect any potential drug interactions.
Piperazinoazepine Tetracyclic
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Mirnite Meltab 15 Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Mirnite Meltab 15 Tablet DT is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. The baby should be monitored for behavioral side effects and adequate growth.
Medical Advice
Mirnite Meltab 15 Tablet DT should be used with caution in patients with kidney disease. Dose adjustment of Mirnite Meltab 15 Tablet DT may be needed. Please consult your doctor.
Exercise Caution
Mirnite Meltab 15 Tablet DT may cause side effects which could affect your ability to drive. Mirnite Meltab 15 Tablet DT can affect your concentration or alertness. This may impair your driving ability.
Consult Doctor
Mirnite Meltab 15 Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Mirnite Meltab 15 Tablet DT may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Mirnite Meltab 15 Tablet DT






